A twice-yearly injection could revolutionize how high blood pressure is treated, offering a major breakthrough for millions ...

Studies show that chronic high blood pressure (hypertension) is associated with a significantly increased risk of renal cell ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

High blood pressure is caused by a combination of factors, such as age, dietary habits, and coexisting conditions. Learn ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Controlling These 8 Risk Factors May Eliminate Early Death Risk for Those With High Blood Pressure May 20, 2025 — Controlling blood pressure is not the only way to treat hypertension.

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

Losing a few kilos can reduce blood pressure. Keeping your waistline healthy also decreases the risk of hypertension. Have at ...

Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase ...

Panelists discuss how current therapeutic strengths include 15 approved treatments with different mechanisms of action that ...